Efficacy of immune checkpoint inhibitors in different types of melanoma

• Main Authors: Ernesto Rossi (Author), Giovanni Schinzari (Author), Brigida Anna Maiorano (Author), Giulia Indellicati (Author), Alessandro Di Stefani (Author), Monica Maria Pagliara (Author), Simona Maria Fragomeni (Author), Erika Valentina De Luca (Author), Maria Grazia Sammarco (Author), Giorgia Garganese (Author), Jacopo Galli (Author), Maria Antonietta Blasi (Author), Gaetano Paludetti (Author), Giovanni Scambia (Author), Ketty Peris (Author), Giampaolo Tortora (Author)
• Format: Book
• Published: Taylor & Francis Group, 2021-01-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Immunotherapy can be used for cutaneous, mucosal, uveal and conjunctival melanoma. Nevertheless, we cannot expect the same benefit from checkpoint inhibitors for all the types of melanoma. The different biological features can explain the variable efficacy. The main results obtained with immune chec...